AQST – aquestive therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

AQST

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/27

05:28 pm

aqst

AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit

Low Report

AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit

Report

3/27

10:52 am

aqst

AQST Shareholder Alert: Aquestive Therapeutics, Inc. Securities Class Action Lawsuit Investors With Losses May Join — The Gross Law Firm

Low Report

AQST Shareholder Alert: Aquestive Therapeutics, Inc. Securities Class Action Lawsuit Investors With Losses May Join — The Gross Law Firm

Report

3/26

03:20 pm

aqst

ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AQST

Low Report

ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AQST

Report

3/26

12:00 pm

aqst

Bronstein, Gewirtz & Grossman LLC Urges Aquestive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Low Report

Bronstein, Gewirtz & Grossman LLC Urges Aquestive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Report

3/26

10:00 am

aqst

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - AQST

Medium Report

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - AQST

Report

3/26

09:00 am

aqst

AQST Lawsuit Alleges Allegedly Concealed Anaphylm NDA Deficiencies - AQUESTIVE THERAPEUTICS, INC. Investors Face Losses Following Allegedly Concealed Anaphylm NDA Deficiencies: SueWallSt

Low Report

AQST Lawsuit Alleges Allegedly Concealed Anaphylm NDA Deficiencies - AQUESTIVE THERAPEUTICS, INC. Investors Face Losses Following Allegedly Concealed Anaphylm NDA Deficiencies: SueWallSt

Report

3/26

09:00 am

aqst

Portnoy Law Firm Announces Class Action on Behalf of Aquestive Therapeutics, Inc. Investors

Low Report

Portnoy Law Firm Announces Class Action on Behalf of Aquestive Therapeutics, Inc. Investors

Report

3/26

08:26 am

aqst

AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aquestive Therapeutics, Inc. Investors of Upcoming Deadline

Neutral Report

AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aquestive Therapeutics, Inc. Investors of Upcoming Deadline

Report

Date

Time

Symbol

Company Name

Action

%Chg

3/4/2026

04:01 pm

aqst

aquestive therapeutics, inc.

MISS Report

-2.1%

aquestive therapeutics, inc.

Report

11/5/2025

04:01 pm

aqst

aquestive therapeutics, inc.

MISS Report

2.2%

aquestive therapeutics, inc.

Report

8/11/2025

04:01 pm

aqst

aquestive therapeutics, inc.

BEAT Report

2.8%

aquestive therapeutics, inc.

Report

5/12/2025

04:01 pm

aqst

aquestive therapeutics, inc.

MISS Report

-19.6%

aquestive therapeutics, inc.

Report

Date

Time

Action

From

Firm

Impact

%Chg

Date

Time

Symbol

Headline

Impact

3/20

07:36 am

aqst

Form 8-K Aquestive Therapeutics, For: Mar 16

Low Report

Form 8-K Aquestive Therapeutics, For: Mar 16

Report

3/11

12:53 pm

aqst

Form 4 Aquestive Therapeutics, For: Mar 09 Filed by: Boyd Peter E.

Low Report

Form 4 Aquestive Therapeutics, For: Mar 09 Filed by: Boyd Peter E.

Report

3/11

12:53 pm

aqst

Form 4 Aquestive Therapeutics, For: Mar 09 Filed by: Barber Daniel

Low Report

Form 4 Aquestive Therapeutics, For: Mar 09 Filed by: Barber Daniel

Report

3/11

12:52 pm

aqst

Form 4 Aquestive Therapeutics, For: Mar 09 Filed by: TOTH A ERNEST JR

Low Report

Form 4 Aquestive Therapeutics, For: Mar 09 Filed by: TOTH A ERNEST JR

Report

3/11

12:52 pm

aqst

Form 4 Aquestive Therapeutics, For: Mar 09 Filed by: BRAENDER LORI J

Low Report

Form 4 Aquestive Therapeutics, For: Mar 09 Filed by: BRAENDER LORI J

Report

3/11

12:52 pm

aqst

Form 4 Aquestive Therapeutics, For: Mar 09 Filed by: Cioffi Melina

Low Report

Form 4 Aquestive Therapeutics, For: Mar 09 Filed by: Cioffi Melina

Report

3/11

12:51 pm

aqst

Form 4 Aquestive Therapeutics, For: Mar 09 Filed by: Korczynski Sherry

Low Report

Form 4 Aquestive Therapeutics, For: Mar 09 Filed by: Korczynski Sherry

Report

3/11

12:51 pm

aqst

Form 4 Aquestive Therapeutics, For: Mar 09 Filed by: Jung Cassie

Low Report

Form 4 Aquestive Therapeutics, For: Mar 09 Filed by: Jung Cassie

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.